Global CDMO Tours & Expert Insights
Get a glimpse into our development, analytical and clinical and commercial manufacturing services across our seven sites.
Meet AGC Biologics, your friendly CDMO expert
Learn About Us
Our CEO, Alberto Santagostino, introduces AGC Biologics and shares what makes us stand out from other CDMOs.
Discover the innovations and processes behind our manufacturing success
Precision in Practice: Optimizing Large-Scale Mammalian Commercial Manufacturing
Hear from our expert Mark Davis, Director of Manufacturing Science and Technology, as he discusses how to optimize large-scale mammalian and mAb manufacturing for commercial supply.
Creating CGT Controls for Seamless Scale-Up from Development to Manufacturing
Learn from AGC Biologics' Process Development Manager, Meghan Nelson, as she speaks on how we ensure successful process development across all scales and prevent issues before they happen.
Check out our video series from our experts in Milan about the future of cell & gene therapy
Addressing Cell Therapy Trends
Listen to Alessandra Gatti, Cell Process Development Director at AGC Biologics talk about emerging trends within the cell therapy industry.
Delivering a GMP Process for ATMPs
Francesca Bellintani, MSAT Director, and overall expert on manufacturing cell and gene therapies shares how her team creates proven cGMP processes.
Building Better Analytical Methods for ATMPs
AGC Biologics' Analytical Method Development Director, Francesca Rossetti, talks about how we are evolving analytical testing capabilities for advanced therapies.
Navigating the Changing ATMP Market
Luca Alberici, Sr. VP and General Manager, of the AGC Biologics site in Milan discusses the changing cell and gene therapy market.
Creating New Standards for ATMP Manufacturing
Dive into how AGC Biologics is shaping the future of manufacturing for advanced therapies with Sabrina Cazzaniga, Sr. Director of GMP Manufacturing.
Building Standardized Viral Vector Platforms
Margherita Neri, Director of Vector Process Development, shares how AGC Biologics has built multiple successful viral vector platforms.
Addressing Regulatory & Quality in Cell and Gene
Listen to Giuliana Vallanti on how AGC Biologics has made quality a priority for all our processes, leading to successful regulatory approval for many advanced therapy products.
Process development speeding up cell & gene therapies
Win the Cell & Gene Therapy Race with Our Process Development
We offer industry-leading process development with more than 95% of our analytics performed in-house.
Virtually tour our sites & facilities across the globe
Seattle Campus Tour
Explore AGC Biologics global headquarters site, providing mammalian and microbial services in Seattle, WA, USA.
Seattle Microbial Line
Take a virtual tour of our new microbial manufacturing line at our Seattle, WA, USA facilities.
Seattle Warehouse Tour
Dive into AGC Biologics' dedicated GMP warehouse servicing the Seattle site facilities.
Copenhagen Campus Tour
Tour AGC Biologics largest site and our EU biologics hub in Copenhagen, Denmark that specializes in mammalian and microbial services.
Heidelberg Facility Tour
Explore our European hub for microbial, plasmid DNA, and messenger RNA with over 40 years of experience in Heidelberg, Germany.
Heidelberg 2023 Expansion
Virtually tour the expansion of AGC Biologics' Heidelberg site, which includes a warehouse, sampling & weighing center, additional lab spaces and expanded microbial, pDNA, and mRNA capabilities.
Milan Facility Tour
The Milan, Italy facility is AGC Biologics' Cell & Gene Center of Excellence and was the first advanced therapy site approved in Europe for GMP manufacturing of clinical and commercial supplies.
Milan 2023 Expansion
The expansion of the Milan facility allows for large-scale commercial viral vector work, suspension capabilities (PD, GMP), both allogeneic and autologous cell therapy, and small-scale fill/finish.
Chiba Facility Tour
The AGC Biologics facility in Chiba is the only CDMO site in Japan with a global resource network and offers mammalian, microbial, and plasmid DNA development and manufacturing.